Serous and mucinous borderline ovarian tumours: Differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates

N/ACitations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background Mucinous and serous borderline ovarian tumours (mBOTs and sBOTs) are controversial diseases. Objectives With this systematic review we aim to evaluate the different high-risk histopathological features and recurrence rates. Search strategy The PubMed database was searched using two terms: {serous AND [(borderline) OR (low malignant potential)] AND ovarian AND tumour} and {mucinous AND [(borderline) OR (low malignant potential)] AND ovarian AND tumour}. Selection criteria Cohorts of either sBOT or mBOT, peer-reviewed, retrospective, or prospective. Data collection and analysis Lethal recurrence data for micropapillary patterns (MPs), microinvasion, non-invasive and invasive implants, and intraepithelial carcinoma (IECA). The primary measure of effect was the odds ratio of lethal recurrence reduction. Results Data from patients in 42 studies including 4414 sBOTs and 12 studies including 894 mBOTs were pooled. Of these, 53.3% presented early-stage typical sBOTs, 24.4% presented with MPs, 22.3% presented with microinvasion, 34.4% presented with non-invasive implants, and 7.3% presented with invasive implants. The pooled lethal recurrence rates were, respectively: 18.3, 16.8, 10.7, 16.2, and 33.8%. Patients with MPs were more likely to suffer lethal recurrence when compared with high-stage sBOTs (odds ratio, OR 0.501; P = 0.003), whereas the trend in microinvasive sBOTs did not reach statistical significance. Regarding mBOTs, 61.6% presented with early-stage typical mBOTs, 19.6% presented with microinvasion, 34.8% presented with IECA, and six patients presented with non-invasive implants; none presented with invasive implants. The lethal recurrence rates were, respectively: 3.6, 0, 3.7, and 0%. Conclusion Micropapillary patterns (MPs) showed a higher risk for lethal recurrence when compared with high-stage sBOTs. Regarding mBOTs, IECA and microinvasion do not play a role in the lethal recurrence rate. Tweetable abstract Micropapillary pattern confirmed as high-risk in BOT. IECA and microinvasion don't play a role in mucinous BOT. Tweetable abstract Micropapillary pattern confirmed as high-risk in BOT. IECA and microinvasion don't play a role in mucinous BOT.

Cite

CITATION STYLE

APA

Vasconcelos, I., Darb-Esfahani, S., & Sehouli, J. (2016, March 1). Serous and mucinous borderline ovarian tumours: Differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates. BJOG: An International Journal of Obstetrics and Gynaecology. Blackwell Publishing Ltd. https://doi.org/10.1111/1471-0528.13840

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free